Vanguard Group Inc Indaptus Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding INDP
# of Institutions
19Shares Held
605KCall Options Held
0Put Options Held
0-
Investment House LLC Las Vegas, NV100KShares$99,9760.01% of portfolio
-
Geode Capital Management, LLC Boston, MA73.1KShares$73,1290.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$45,3360.01% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ44.1KShares$44,0850.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny27.1KShares$27,1000.0% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $8.26M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...